Product Overview & Details for George Washington University 2025 Hematology and Oncology Best Practices- On-Demand Full Session Course
Videos+PDFs
Target Audience
This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.
Learning Objectives
At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Oncology
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Comprehend the principles of management of gynecologic and other genito-urinary malignancies
- Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Recognize principles of new developments in biologic therapy of cancer
Program Agenda
COURSE CONTENT
This online course is divided into 3 modules:
 2025 HEMONC Best Practices Course Syllabus FULL SESSION COURSE.pdf
Hematology Sessions:
- Session 0 (Hematology): Anemias, Porpyrias, Red Cell Enzymes, Clotting, Cellular Morphology and Liquid Biopsies (4.00 hours)
- Session 1: Iron Deficiency, Hemoglobinopathies, Hemolytic Anemia, Hemophilias, Transfusion Medicine, Hematologic Complications of Pregnancy and Platelet Alloimmunization (9.00 hours)
- Session 2: Sickling Disorders, Consumptive Thrombohemorrhagic Disorders, Bone Marrow Failure, White Cell Disorders, DIC, HIT, VITT, Ischemic Limb Gangrene, ABO Incompatibility, ITP Drug-Induced Thrombocytopenia and Hematopoietic Transplantation (8.75 hours)
Hematologic Malignancies Sessions:
- Session 3: Lymphomas, Multiple Myeloma, MGUS, ALL, CML, Plasma Cell Disorders, Myelodysplasia, Waldenstrom’s Macroglobulinemia and Palliative Care (9.25 hours)
- Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms, CLL, Pharmacology and T Cell Therapies (9.25 hours)
Medical Oncology Sessions:
- Session 5:Â Head/Neck Cancer, Familial Cancer Syndromes, Lung Cancer, Breast Cancer, Lung Cancer, Neuro-Oncology and Endocrine Malignancies (9.00 hours)
- Session 6: Renal Cell, Prostate, Bladder, Testicular, Ovarian, Endometrial Tumors, Melanoma, Carcinoid Tumors and Mesothelioma (10.00 hours)
- Session 7:Â GI Oncology, Pancreatic Cancer and Sarcomas (6.75 hours)
